Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024927
Filing Date
2021-05-06
Accepted
2021-05-06 16:01:24
Documents
57
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q crnx-10q_20210331.htm   iXBRL 10-Q 1371547
2 EX-10.1 crnx-ex101_251.htm EX-10.1 24896
3 EX-31.1 crnx-ex311_8.htm EX-31.1 21620
4 EX-31.2 crnx-ex312_7.htm EX-31.2 21573
5 EX-32.1 crnx-ex321_6.htm EX-32.1 6918
  Complete submission text file 0001564590-21-024927.txt   5694017

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA crnx-20210331.xsd EX-101.SCH 36645
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crnx-20210331_cal.xml EX-101.CAL 39856
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crnx-20210331_def.xml EX-101.DEF 110600
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE crnx-20210331_lab.xml EX-101.LAB 336122
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crnx-20210331_pre.xml EX-101.PRE 246775
11 EXTRACTED XBRL INSTANCE DOCUMENT crnx-10q_20210331_htm.xml XML 1070306
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

EIN.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38583 | Film No.: 21897574
SIC: 2834 Pharmaceutical Preparations